A detailed history of Uma Financial Services, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Uma Financial Services, Inc. holds 65 shares of BMRN stock, worth $3,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 106 38.68%
Holding current value
$3,557
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$52.62 - $61.93 $2,157 - $2,539
-41 Reduced 38.68%
65 $3,000
Q2 2025

Jul 11, 2025

SELL
$54.08 - $68.32 $540 - $683
-10 Reduced 8.62%
106 $5,000
Q1 2025

Apr 28, 2025

BUY
$61.25 - $72.83 $612 - $728
10 Added 9.43%
116 $8,000
Q4 2024

Feb 12, 2025

BUY
$61.93 - $70.49 $6,564 - $7,471
106 New
106 $6,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.